A corticosteroid injection into the base of the affected finger is the most common first-line medical treatment for trigger finger, and it resolves the problem completely in roughly two out of three cases.1PubMed Central. The efficacy of steroid injection in the treatment of trigger finger The procedure takes a few minutes in a clinic setting and typically involves a small volume of steroid delivered right next to the thickened tissue that is causing the finger to catch or lock. The reality behind that two-thirds figure, though, depends on which finger is involved, how many injections you get, whether you have diabetes, and which steroid your doctor reaches for.
What the Injection Actually Does
Trigger finger happens when the tunnel your flexor tendon slides through, called the A1 pulley, becomes thickened and constricted. The tendon catches as it tries to glide, producing that characteristic clicking, locking, or painful snapping when you try to straighten the finger.2PubMed Central. Trigger finger: etiology, evaluation, and treatment The underlying tissue change is not simply inflammation in the way most people picture it. Biopsies of affected pulleys show a buildup of cartilage-like cells and extra surrounding tissue, a process researchers describe as fibrocartilage metaplasia, meaning the pulley is being gradually remodeled into something tougher and less flexible.3The Journal of Hand Surgery. Pathobiology of the human A1 pulley in trigger finger
A corticosteroid injection works by delivering a potent anti-inflammatory agent directly alongside the thickened pulley. The steroid shrinks swelling, quiets the local tissue reaction, and gives the tendon enough room to glide smoothly again. Pain tends to ease within days, while the mechanical catching or locking can take a few weeks to fully resolve.4PubMed Central. Trigger Finger? Just Shoot! Because the tissue remodeling in the pulley is structural and not purely inflammatory, the injection does not always produce a permanent fix, which is why recurrence is a central question for anyone considering this treatment.
How Often a Single Injection Is Enough
Short-term success rates are encouraging. In the weeks following a single steroid injection, studies consistently report that somewhere around two-thirds of treated fingers improve significantly.5PubMed Central. The efficacy of steroid injection in the treatment of trigger finger The catch is durability. A long-term follow-up study found that only about 45% of patients still considered themselves successfully treated after a single injection when tracked over an extended period.6PubMed Central. Long-Term Outcomes Following a Single Corticosteroid Injection for Trigger Finger That gap between the initial relief rate and the lasting cure rate is the reason many people end up back in the office for a second shot or eventually for surgery.
One detail that sometimes surprises patients: the thumb tends to respond differently than the other fingers. The study reporting the 66% overall success rate found a statistically meaningful difference between the thumb and the fingers, with the thumb being harder to treat.7PubMed Central. The efficacy of steroid injection in the treatment of trigger finger Meanwhile, the severity of triggering at the time of injection, whether a palpable nodule was present, and whether the patient had other medical conditions did not clearly predict success or failure in that same study.
When a Second or Third Injection Makes Sense
If the first injection fails or the finger relapses after months of relief, a repeat injection is a reasonable next step, though the returns diminish. A study tracking second injections found that about 39% of those fingers achieved long-term success, and the median time before symptoms returned was roughly a year.8PubMed Central. Long-Term Effectiveness of Repeat Corticosteroid Injections for Trigger Finger A third injection showed a similar timeline but pushed more patients toward eventual surgical release.
A prospective study looking at repeated injections painted a more nuanced picture of how success erodes over time. At one month after a repeat injection, relief was near-universal at about 97%. By three months, that dropped to roughly 84%. At six months, about 68% still had good results, and by one year, only about half remained symptom-free.9PubMed. Factors Influencing the Successful Treatment of Recurrent Trigger Finger With Repeated Corticosteroid Injections: A Prospective Cohort Study The takeaway is that repeat injections can absolutely buy you time, sometimes years, but the probability of eventually needing surgery increases with each recurrence.
From a cost-effectiveness standpoint, offering up to three steroid injections before moving to surgery turned out to be the most economical strategy for both commercially insured and Medicare patients in one analysis.10PubMed. A Cost-Effectiveness Analysis of Corticosteroid Injections and Open Surgical Release for Trigger Finger Jumping straight to surgery only became the better financial choice when surgical costs fell well below typical levels. So the standard approach of trying injections first and reserving surgery for persistent cases is backed by both clinical evidence and economic modeling.
Which Steroid Formulation Your Doctor Picks Matters
Not all corticosteroid preparations perform equally. A systematic review of randomized trials comparing different steroid formulations reported that methylprednisolone achieved an overall remission rate of about 84%, while triamcinolone came in at roughly 45%.11PubMed. Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials That is a large gap. Methylprednisolone also had no reported adverse events in the reviewed trials, whereas triamcinolone carried a small but real rate of side effects around 3%, including skin changes and steroid flare reactions.
If you are seeing a hand specialist, they may already prefer one formulation based on their experience. But if your injection fails and you know triamcinolone was used, it is worth asking whether switching to methylprednisolone might improve the odds on a second attempt. Most patients never think to ask about the specific drug being injected, and many clinicians default to whichever steroid their office stocks.
The Diabetes Problem
Trigger finger is much more common in people with diabetes, and unfortunately, steroid injections work less reliably in this group. The evidence here is consistent but the magnitude varies across studies. One study found injection success rates of about 72% in non-diabetic patients but 57% in diabetic patients, though the difference was not statistically significant given the sample size.12Journal of Hand Surgery. Long-Term Effectiveness of Corticosteroid Injections for Trigger Finger and Thumb Another found a more dramatic split: 57% success in non-diabetic digits versus just 32% in diabetic ones, and that gap was statistically significant. Every patient with type 1 diabetes in that study ended up needing surgery.13American Journal of Physical Medicine & Rehabilitation. Steroid Injections in the Management of Trigger Fingers
Perhaps the most striking evidence came from a controlled trial that included a placebo group of diabetic patients receiving a sham injection. In non-diabetic patients, steroid injections worked well, with about 86% success. In the diabetic group, the steroid injection did not significantly outperform the placebo, and patients with diabetes ended up needing surgery at much higher rates regardless of whether they received the steroid.14Journal of Bone and Joint Surgery. Corticosteroid Injection in Diabetic Patients with Trigger Finger That finding raises uncomfortable questions about whether steroid injections are worth attempting in diabetic patients at all, or whether they simply delay an inevitable surgery. Many hand surgeons still offer a trial injection because the procedure is low-risk and some diabetic patients do respond, but the conversation should be more candid about reduced odds.
Blood Sugar Spikes After the Shot
Beyond the lower cure rate, diabetic patients face a practical concern: corticosteroid injections temporarily raise blood glucose. One study tracked fasting blood sugar levels after hand and wrist injections and found a significant spike on the first day after injection, averaging about 43 points above baseline. By day two the increase had shrunk to about 17 points, and by day four, levels were back to normal.15PubMed Central. Blood glucose levels in diabetic patients following corticosteroid injections into the hand and wrist
Another study found even larger swings: blood glucose jumped an average of 73% above baseline on the first morning after injection. In patients with type 1 diabetes, the spike was even more dramatic, averaging 145% above baseline on day one and remaining about 22% elevated through day five.16PubMed. The effect of corticosteroid injection for trigger finger on blood glucose level in diabetic patients For most people with well-controlled type 2 diabetes, a few days of elevated blood sugar is manageable with extra monitoring and possibly a temporary medication adjustment. For someone with brittle type 1 diabetes or very poor control, the blood sugar disruption deserves serious consideration and a discussion with the prescribing physician beforehand.
Side Effects and Safety
Steroid injections for trigger finger are generally safe, but they are not side-effect-free. The most commonly discussed local complications are subcutaneous tissue thinning (sometimes called fat atrophy or fat necrosis) and skin depigmentation at the injection site. One study following over 160 digits found tissue atrophy in less than 1% of cases and skin color changes in about 1%.17Arch Hand Microsurg. Steroid injection using tendon excursion for trigger finger: introduction to injection methods and analysis of treatment results The depigmentation is more visible in people with darker skin and is usually but not always reversible over months.
A concern that comes up in online forums is whether repeated injections might weaken or tear the flexor tendon. A retrospective study looked specifically at whether prior trigger finger injections were associated with tendon tearing found during surgery. The majority of tearing cases had no prior injections at all, and statistical analysis showed no significant link between the number of injections and tendon damage.18The Journal of the American Osteopathic Academy of Orthopedics. Retrospective Study Investigating Whether Trigger Finger Injections Are Associated with Attritional Tearing of the Flexor Tendons Seen Intraoperatively A separate study that used low-dose steroid without limiting injection frequency also reported zero cases of tendon rupture or infection.19PubMed Central. Safety and Efficacy of Low-Dose Triamcinolone Injection without Injection Frequency Limitation for Trigger Finger The evidence at this point does not support the idea that a few steroid injections meaningfully threaten your tendon, though most surgeons prefer to cap repeat injections at two or three in the same digit as a precaution.
Does Ultrasound Guidance Improve Results?
Some clinicians use ultrasound imaging to guide the needle directly to the A1 pulley, while most perform the injection using anatomical landmarks alone. You might assume the image-guided approach would produce clearly better outcomes, but the evidence is mixed. A prospective study comparing the two found that ultrasound-guided injections led to faster symptom resolution, earlier return to work, and less pain in the first four weeks. However, by three and six months, there was no significant difference in pain scores or functional outcomes between the two groups.20PubMed Central. Ultrasound guided versus blinded injection in trigger finger treatment: a prospective controlled study
A second study found comparable improvements in disease severity, pain, and function between ultrasound-guided and landmark-based injections, with no statistically significant advantage for either group at follow-up.21Zahedan Journal of Research in Medical Sciences. Comparable Clinical Outcomes with Ultrasound-Guided and Blind Corticosteroid Injections in Trigger Finger Management The practical interpretation: ultrasound guidance may speed up early recovery, but it does not appear to change your final outcome. If your doctor offers it and it does not add significant cost, it may be worth having. But you are not getting an inferior treatment if your injection is done by landmarks, which is how the vast majority of trigger finger injections are performed worldwide.
What the Injection Feels Like
A question many patients have but few ask before the appointment: how much does it hurt? The injection is given at the base of the finger, typically on the palm side, and involves a relatively small needle. Some doctors mix a local anesthetic like lidocaine with the steroid, reasoning that it will reduce pain. Counterintuitively, a randomized trial found the opposite. Injections that included lidocaine with epinephrine actually produced higher pain scores immediately after injection compared to steroid alone.22PubMed Central. Trigger Finger Corticosteroid Injection With and Without Local Anesthetic: A Randomized, Double-Blind Controlled Trial The likely explanation is that the added volume and the acidic pH of the anesthetic solution increase tissue pressure and stinging at the injection site. Pain scores in both groups were moderate (around 2 to 3.5 on a 10-point scale), so the procedure is tolerable either way, but if your doctor gives you the option, skipping the anesthetic may actually mean less discomfort during the injection itself, with the trade-off being no brief numbing period afterward.
How Injections Compare to Surgery and Splinting
Corticosteroid injections sit in the middle of the treatment ladder for trigger finger. Below them is splinting, which involves wearing a brace that keeps the finger from fully bending for several weeks. A narrative review concluded that steroid injection offers faster and better short-term symptom relief than splinting, NSAIDs, or physical therapy, but comes with higher recurrence rates over the long run.23Journal of Orthopaedic Reports. Conservative management of trigger finger with steroid injections: A narrative literature review Splinting is slower (six to nine weeks for gradual improvement versus days for pain relief with an injection), but for patients who want to avoid needles entirely or who have reasons to avoid steroids, it remains a reasonable option for milder cases.
Above injections on the treatment ladder is surgical release, which involves cutting the A1 pulley to permanently free the tendon. Surgery has a very high long-term success rate, but it involves an incision, a recovery period, and significantly higher cost. A network meta-analysis of randomized trials produced an interesting finding: corticosteroid injection was ranked as the most likely intervention to be the most effective at reducing disease severity at both short-term and long-term time points, outperforming even open surgery.24Scientific Reports. A systematic review and network meta-analysis of randomized controlled trials on the treatment of trigger finger That does not mean injections are categorically better than surgery. The trials contributing to that analysis measure disease severity on a scale, not recurrence over years, and surgery’s main advantage is its durability, not its superiority at any single time point. Still, the finding reinforces why injections remain the go-to first treatment: they reduce symptoms more dramatically than surgery does at each measured follow-up, and only their higher recurrence rate keeps surgery in the conversation.
Hyaluronic Acid as an Alternative Injection
Corticosteroids are not the only injectable option being studied. Hyaluronic acid, a substance better known for knee osteoarthritis injections, has shown promise for trigger finger. The same network meta-analysis that ranked corticosteroid injection highest also found that hyaluronic acid injection significantly reduced disease severity compared to open surgery at both short-term and long-term follow-up, with effectiveness close to that of corticosteroids.25Scientific Reports. A systematic review and network meta-analysis of randomized controlled trials on the treatment of trigger finger Hyaluronic acid works differently from steroids; rather than suppressing inflammation, it acts as a lubricant and may help the tendon glide more easily through the constricted pulley.
Hyaluronic acid injections for trigger finger are not yet standard practice in most countries and may not be covered by insurance for this purpose. But for patients who respond poorly to steroids, cannot tolerate blood sugar disruptions, or have concerns about repeated steroid exposure, it represents a potential alternative worth discussing with a hand specialist. The evidence base is still smaller than for corticosteroids, so it is an area to watch rather than a settled recommendation.
What to Expect After the Injection
The procedure itself is fast. You will feel pressure at the base of the finger and a brief sting. Afterward, the injection site may be sore for a day or two. Pain from the trigger finger itself often improves within a few days, but the mechanical catching or locking usually takes longer to resolve, sometimes several weeks.26PubMed Central. Trigger Finger? Just Shoot! Some doctors ask you to rest the hand for 24 to 48 hours; others encourage gentle use right away. There is no standardized post-injection protocol for trigger finger, and most people return to normal activities within a day or two.
If the finger is no better after two to three weeks, or if improvement is only partial, a follow-up visit to discuss a repeat injection or other options is appropriate. If you have had two or three injections without lasting relief, most hand surgeons will recommend surgical release at that point. The surgery is typically done under local anesthesia as an outpatient procedure, involves a small incision at the base of the finger, and has a recovery period of a few weeks before you regain full grip strength. For the majority of people, though, that first injection resolves the problem without ever reaching the surgical discussion.